These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2788833)

  • 1. Regional brain glucose metabolism in neuroacanthocytosis.
    Dubinsky RM; Hallett M; Levey R; Di Chiro G
    Neurology; 1989 Sep; 39(9):1253-5. PubMed ID: 2788833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemiballismus: study of a case using positron emission tomography with 18fluoro-2-deoxyglucose.
    Dubinsky RM; Greenberg M; Di Chiro G; Baker M; Hallett M
    Mov Disord; 1989; 4(4):310-9. PubMed ID: 2811890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rett syndrome: positron emission tomography (PET) studies.
    Wagner HN
    Am J Med Genet Suppl; 1986; 1():211-24. PubMed ID: 3087184
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroacanthocytosis and aprebetalipoproteinemia.
    Bohlega S; Riley W; Powe J; Baynton R; Roberts G
    Neurology; 1998 Jun; 50(6):1912-4. PubMed ID: 9633762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study].
    Hanakawa T; Fukuyama H; Akiguchi I; Kato M; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1996 May; 36(5):655-60. PubMed ID: 8905984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain metabolism in mitochondrial encephalomyopathy: a PET study.
    De Volder A; Ghilain S; de Barsy T; Goffinet AM
    J Comput Assist Tomogr; 1988; 12(5):854-7. PubMed ID: 3262636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement disorders of familial neuroacanthocytosis syndrome.
    Yamamoto T; Hirose G; Shimazaki K; Takado S; Kosoegawa H; Saeki M
    Arch Neurol; 1982 May; 39(5):298-301. PubMed ID: 7073550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study.
    DeVolder AG; Goffinet AM; Bol A; Michel C; de Barsy T; Laterre C
    Arch Neurol; 1990 Feb; 47(2):197-204. PubMed ID: 2302091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET).
    De Volder A; Bol A; Michel C; Cogneau M; Evrard P; Lyon G; Goffinet AM
    Brain Dev; 1988; 10(1):47-50. PubMed ID: 2967038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.
    Balestri P; Lucignani G; Fois A; Magliani L; Calistri L; Grana C; Di Bartolo RM; Perani D; Fazio F
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1479-83. PubMed ID: 7798976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional cerebral glucose metabolism differs in adult and rigid juvenile forms of Huntington disease.
    Matthews PM; Evans AC; Andermann F; Hakim AM
    Pediatr Neurol; 1989; 5(6):353-6. PubMed ID: 2532511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.
    Suhonen-Polvi H; Ruotsalainen U; Ahonen A; Haaparanta M; Aho K; Riikonen R; Kero P; Korvenranta H; Simell O; Wegelius U
    Acta Radiol Suppl; 1991; 376():173. PubMed ID: 1666770
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia.
    Chase TN; Tamminga CA; Burrows H
    Adv Neurol; 1988; 50():237-41. PubMed ID: 3261115
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH
    Ann Neurol; 1984 May; 15(5):419-24. PubMed ID: 6610384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism in the caudate nuclei of patients with eating disorders, measured by PET.
    Krieg JC; Holthoff V; Schreiber W; Pirke KM; Herholz K
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):331-3. PubMed ID: 1831664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral glucose metabolism in the course of subacute sclerosing panencephalitis.
    Huber M; Herholz K; Pawlik G; Szelies B; Jürgens R; Heiss WD
    Arch Neurol; 1989 Jan; 46(1):97-100. PubMed ID: 2783367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.